Dupilumab beneficial in moderate-to-severe Atopic Dermatitis Vinay Singh singh20 Sept 2018 7:28 PM ISTDupixent (dupilumab) monotherapy resulted in significant improvements in the signs and symptoms of atopic dermatitis, according to the findings of...
Eczema drug restores hair growth in longstanding alopecia Medha Baranwal Baranwal14 Oct 2018 8:10 PM ISTMaryanne M. Senna, Department of Dermatology, Massachusetts General Hospital, Boston, and colleagues in a case report published in the journal JAMA...
Dupilumab eliminates steroid need in half asthma patients Vinay Singh singh20 Oct 2018 8:28 PM ISTThe U.S. Food and Drug Administration has approved Dupilumab as an add-on maintenance therapy in patients with moderate-to-severe asthma, announced...
Add on Dupilumab reduces asthma exacerbations Medha Baranwal Baranwal23 Nov 2018 7:28 PM ISTPatients with allergic asthma when provided add-on treatment with the biologic therapy dupilumab (Dupixent), resulted in improved lung function and...
European Commission approves Dupilumab for Severe Asthma Hina Zahid8 May 2019 7:20 PM ISTEuropean Commission has approved Dupilumab mab for Severe Asthma.It is the only biologic approved in the EU for severe asthma with type 2...
Dupilumab reduces exacerbation rates in asthma patients Medha Baranwal Baranwal24 May 2019 7:28 PM ISTDupilumab significantly reduced severe exacerbation rates in patients with late-onset asthma with or without fixed airway obstruction, according to a...
FDA approves dupilumab for chronic rhinosinusitis with nasal polyps in adults Dr. Kamal Kant Kohli Kohli26 Jun 2019 7:27 PM ISTFood and Drug Administration, FDA approves first nonsurgical treatment for inadequately controlled chronic rhinosinusitis with nasal polyps in adults....
Dupilumab significantly improves severe atopic dermatitis in children, finds clinical trial Medha Baranwal Baranwal11 Aug 2019 8:28 PM ISTDelhi: Dupilumab (Dupixent) combined with topical corticosteroids significantly improved the symptoms of severe atopic dermatitis (AD) in children,...
Atopic dermatitis patient reports acute Arthritis and polyarthralgia after using Dupilumab Deepanjana Sarkar25 Sept 2019 6:00 PM ISTDupilumab is the first FDA approved injectable indicated for the treatment of adults with moderate to severe atopic dermatitis (AD) whose disease is...
Dupilumab may benefit patients of severe chronic rhinosinusitis with nasal polyps: Lancet Dr. Kamal Kant Kohli Kohli4 Oct 2019 8:10 PM ISTDelhi: Dupilumab addition to daily standard of care is beneficial for patients with severe chronic rhinosinusitis with nasal polyps (CRSwNP) who...
Dupilumab reduces exacerbation in both early and late onset asthma: CHEST Medha Baranwal Baranwal10 Nov 2019 7:20 PM ISTUSA: Dupilumab, a fully human monoclonal antibody, is beneficial for patients with early-or late-onset asthma, finds a recent study published in the...
New Guidelines for Management of Severe Atopic Dermatitis released Hina Zahid25 Jan 2019 7:00 PM ISTComprehensive guidelines for Management of severe atopic dermatitis (AD) has been developed and released by a team of investigators from the...
